Cyclerion Therapeutics,Inc. (CYCN)
US Market

Cyclerion Therapeutics Financial Statements


Cyclerion Therapeutics Financial Overview

Cyclerion Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.115; its P/E ratio is -0.77; Cyclerion Therapeutics is scheduled to report earnings on November 9, 2022, and the estimated EPS forecast is $-0.31. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Dec 21Sep 21Jun 21
Income Statement
Total Revenue$ 72.00K$ 225.00K$ 182.00K$ 77.00K$ 3.00M
Gross Profit$ ―$ ―$ ―$ ―$ ―
EBIT$ -13.43M$ -12.98M$ -11.65M$ -11.29M$ -16.18M
EBITDA$ -13.42M$ -12.94M$ -11.61M$ -11.24M$ -16.06M
Net Income Common Stockholders$ -13.39M$ -12.98M$ -10.78M$ -11.29M$ -16.18M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 30.32M$ 41.13M$ 41.43M$ 53.96M$ 54.40M
Total Assets$ 35.21M$ 46.52M$ 59.33M$ 67.74M$ 75.73M
Total Debt$ 3.51M$ 44.71M$ 45.73M$ 46.68M$ 0.00
Net Debt$ -26.81M$ 3.58M$ 4.31M$ -7.28M$ -54.40M
Total Liabilities$ 9.85M$ 9.49M$ 11.09M$ 11.36M$ 10.51M
Stockholders Equity$ 25.36M$ 37.03M$ 48.25M$ 48.43M$ 56.39M
Cash Flow
Free Cash Flow$ -10.82M$ -12.84M$ -8.63M$ -7.93M$ -5.51M
Operating Cash Flow$ -10.82M$ -12.84M$ -8.63M$ -7.92M$ -5.51M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ -7.00K$ 2.00K
Financing Cash Flow$ 17.00K$ 0.00$ 85.00K$ 43.00K$ 30.63M
Currency in USD

Cyclerion Therapeutics Earnings and Revenue History

Cyclerion Therapeutics Debt to Assets

Cyclerion Therapeutics Cash Flow

Cyclerion Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis